Enovis ENOV
NYSE ENOV
$18.61 -0.42 (-2.21%)
As of: Sep 10, 2026 · 10:52 AM EDT

Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026)

Enovis' (ENOV) quarterly Other Non-Current Liabilities came in at $368.6 million in Q3 2026, down 18.18% year-over-year from $450.6 million in Q3 2025, and down 6.39% quarter-over-quarter from $393.8 million in Q2 2026.

Analysis

Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Other Non-Current Liabilities for 17 consecutive years, with $368.6 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 18.18% year-over-year to $368.6 million in Q3 2026; TTM through Jul 2026 was $368.6 million, a 18.18% decrease from a year earlier, with the FY2025 full-year figure at $424.6 million, up 61.12% from the prior year.
  • Other Non-Current Liabilities was $368.6 million for Q3 2026 at Enovis, down from $393.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $601.0 million in Q2 2022 and troughed at $130.7 million in Q3 2022.
  • A 5-year average of $293.7 million and a median of $259.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities sank 79.17% in 2022 and jumped 96.44% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $167.0 million in 2022, then advanced by 22.27% to $204.2 million in 2023, then gained by 29.06% to $263.5 million in 2024, then soared by 61.12% to $424.6 million in 2025, then declined by 13.18% to $368.6 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $368.6 million (Q3 2026), $393.8 million (Q2 2026), and $424.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.92 Bn 176.31 Bn 7.27 Bn
2 Intuitive Surgical 127.64 Bn 122.42 Bn 1.96 Bn
3 Medtronic 117.92 Bn 109.10 Bn 6.34 Bn
4 Stryker 105.39 Bn 101.91 Bn 4.50 Bn
5 Boston Scientific 64.88 Bn 64.34 Bn 3.85 Bn
6 Edwards Lifesciences 49.92 Bn 45.66 Bn 1.35 Bn
7 Alcon 33.24 Bn 31.79 Bn 1.68 Bn
8 Dexcom 32.12 Bn 30.18 Bn 830.00 Mn
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn
10 Enovis 1.08 Bn 1.06 Bn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 368.63 Mn
Apr 3, 2026 393.81 Mn
Dec 31, 2025 424.57 Mn
Oct 3, 2025 437.01 Mn
Jul 4, 2025 450.56 Mn
Apr 4, 2025 360.70 Mn
Dec 31, 2024 263.52 Mn
Sep 27, 2024 313.76 Mn
Jun 28, 2024 255.20 Mn
Mar 29, 2024 249.05 Mn
Dec 31, 2023 204.18 Mn
Sep 29, 2023 159.73 Mn
Jun 30, 2023 191.55 Mn
Mar 31, 2023 170.53 Mn
Dec 31, 2022 166.99 Mn
Sep 30, 2022 130.67 Mn
Jul 1, 2022 144.24 Mn
Apr 1, 2022 601.02 Mn
Dec 31, 2021 122.16 Mn
Oct 1, 2021 627.37 Mn